Major Antibiotic Classes
Antibiotics are organized into several major structural and mechanistic classes: β-lactams (including penicillins, cephalosporins, carbapenems, and monobactams), fluoroquinolones, macrolides/azalides, aminoglycosides, tetracyclines, glycopeptides, oxazolidinones, lincosamides, and sulfonamides. 1, 2
β-Lactam Antibiotics
The β-lactam class is characterized by a four-membered β-lactam ring that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), ultimately causing bacterial autolysis. 1, 3
Penicillins
Natural penicillins (penicillin G, penicillin V) are the treatment of choice for streptococcal infections, primarily targeting Gram-positive cocci including Streptococcus pneumoniae and Streptococcus pyogenes. 4
Penicillinase-resistant penicillins (dicloxacillin, nafcillin, flucloxacillin) specifically target methicillin-susceptible Staphylococcus aureus (MSSA). 4
Aminopenicillins (amoxicillin, ampicillin) represent the most active oral β-lactams against pneumococci due to excellent bioavailability, covering streptococci and some Gram-negative organisms like Escherichia coli and Proteus mirabilis. 1, 4
β-lactam/β-lactamase inhibitor combinations (amoxicillin-clavulanate, ampicillin-sulbactam, piperacillin-tazobactam) preserve β-lactam activity against β-lactamase-producing organisms. 1 Amoxicillin-clavulanate is the first-choice oral agent for skin/soft tissue infections, covering MSSA, streptococci, H. influenzae, Moraxella catarrhalis, and anaerobes. 4 Piperacillin-tazobactam has very broad spectrum including P. aeruginosa, Enterobacteriaceae, MSSA, streptococci, and anaerobes. 4
Cephalosporins
Cephalosporins are organized by generation, with modifications to broaden antimicrobial spectrum and increase β-lactamase stability. 1
First-generation (cefazolin, cephalexin) are most active against MSSA and streptococci, covering Klebsiella, E. coli, and P. mirabilis. 4
Second-generation (cefuroxime) provide expanded Gram-negative coverage. 1
Third-generation (ceftriaxone, cefotaxime, ceftazidime) offer broad Gram-negative coverage, with ceftazidime specifically covering Pseudomonas. 1
Fourth-generation (cefepime) provide enhanced activity against both Gram-positive and Gram-negative organisms including Pseudomonas. 1
Carbapenems
- Carbapenems (ertapenem, meropenem, imipenem) provide the broadest antimicrobial spectrum of all β-lactams, covering essentially all pathogenic organisms except MRSA and vancomycin-resistant enterococci. 1, 4 Ertapenem (group 1 carbapenem) lacks Pseudomonas coverage, while meropenem and imipenem (group 2 carbapenems) cover Pseudomonas. 1
Monobactams
- Monobactams (aztreonam) are activated by sulfonic, phosphoric, or carboxyl groups and possess β-lactamase stability related to their C-4 grouping. 3
Fluoroquinolones
Fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin, gatifloxacin) provide broad-spectrum activity for respiratory, urinary, and gastrointestinal infections. 1, 2 Respiratory fluoroquinolones (levofloxacin, moxifloxacin, gatifloxacin) have the greatest in vitro activity against predominant respiratory pathogens, with 99% activity against S. pneumoniae. 1
Macrolides and Azalides
Macrolides (erythromycin, clarithromycin) and azalides (azithromycin) are effective for respiratory infections, particularly community-acquired pneumonia, due to their effectiveness against Gram-positive bacteria and atypical pathogens. 1, 2 They demonstrate 63-75% activity against S. pneumoniae and 100% activity against M. catarrhalis. 1
Aminoglycosides
Aminoglycosides (gentamicin, tobramycin, amikacin) are often used in combination with β-lactams for serious Gram-negative infections, including Pseudomonas aeruginosa. 2
Tetracyclines
Tetracyclines (doxycycline, minocycline) are recommended for atypical infections, rickettsial diseases, and some skin infections. 2 Doxycycline demonstrates 25% activity against H. influenzae and 78-96% activity against M. catarrhalis. 1
Glycopeptides
Glycopeptides (vancomycin, teicoplanin) are reserved for serious infections with resistant Gram-positive bacteria, including MRSA, and are active exclusively against Gram-positive organisms. 1, 2, 4
Oxazolidinones
Oxazolidinones (linezolid) are effective for MRSA and VRE infections due to their unique mechanism of action and effectiveness against resistant Gram-positive bacteria. 2, 4
Lincosamides
Lincosamides (clindamycin) are bacteriostatic against Gram-positive organisms including MSSA, S. pneumoniae, and S. pyogenes, useful for impetigo, purulent skin/soft tissue infections, and necrotizing fasciitis. 1, 4 Clindamycin demonstrates 90-92% activity against S. pneumoniae. 1
Sulfonamides
Sulfonamides (trimethoprim-sulfamethoxazole) demonstrate 63-75% activity against S. pneumoniae, 70-85% activity against H. influenzae, and 20% activity against M. catarrhalis. 1
Common Pitfall
Cephalosporins are inherently less active than penicillin/amoxicillin against S. pneumoniae, with baseline MICs fourfold higher than amoxicillin, and their active absorption in the gastrointestinal tract limits achievable concentrations regardless of dose. 1